Urovant Sciences Q2 EPS $(0.85) Beats $(1.15) Estimate

Urovant Sciences (NASDAQ:UROV) reported quarterly losses of $(0.85) per share which beat the analyst consensus estimate of $(1.15) by 26.09 percent. This is a 30.89 percent increase over losses of $(1.23) per share from

Benzinga · 11/05/2019 21:20

Urovant Sciences (NASDAQ:UROV) reported quarterly losses of $(0.85) per share which beat the analyst consensus estimate of $(1.15) by 26.09 percent. This is a 30.89 percent increase over losses of $(1.23) per share from the same period last year.